Summary: Extracellular histamine in the striatum of con scious freely moving rats collected by intracerebral mi crodialysis 1 day after implantation of a V-shaped dialysis probe was measured by HPLC coupled with postcolumn o-phthalaldehyde derivatization fluorometry. The basal fractional histamine outputs were almost constant from 1 to 7 h after the start of perfusion (5.9-8.4 pg/30 min). Depolarization by perfusion with a high K + (100 mM) containing medium produced a significant (124%) in crease and neuronal blockade by perfusion with a tetro dotoxin (1 jLM)-containing medium resulted in a 68% re duction in the histamine output. The histamine output was markedly reduced by intraperitoneal injection of o:-fluoromethylhistidine (100 mg/kg) , an irreversible in hibitor of histidine decarboxylase, or (R)-o:-methyl histamine (5 mg/kg), a potent and specific H3-receptor Histamine (HA) exists in at least two classes of cellular stores in the mammalian brain, i. e., neurons and mast cells (Schwartz et a!. , 1986) . Histaminer gic fibers are widely distributed in the brain, origi nating from cell bodies in the posterior hypothala mus (Watanabe et a!. , 1984) , and histaminergic in nervation of the cerebral microvasculature has also been demonstrated (Steinbusch and Verhofstad, 1986; Takagi et a!. , 1986) .
Histamine (HA) exists in at least two classes of cellular stores in the mammalian brain, i. e., neurons and mast cells (Schwartz et a!. , 1986) . Histaminer gic fibers are widely distributed in the brain, origi nating from cell bodies in the posterior hypothala mus (Watanabe et a!. , 1984) , and histaminergic in nervation of the cerebral microvasculature has also been demonstrated (Steinbusch and Verhofstad, 1986; Takagi et a!. , 1986) .
There is some evidence that brain HA may play an important role in the regulation of blood-brain barrier (BBB) permeability: carotid artery infusion of HA increases BBB permeability (Dux and J06,  agonist. After middle cerebral artery (MCA) occlusion, the histamine output gradually increased, and reached four times the control value 8 h later. When rats were pretreated with metoprine (10 mg/kg), a histamine N methyltransferase inhibitor, there was no significant dif ference in the histamine output between the MCA occluded and the sham-operated groups during the first 3.5 h after the operation, but the histamine output grad ually increased thereafter in the MCA-occluded group. In rats treated with o:-fluoromethylhistidine, MCA occlusion failed to cause an increase in the histamine output. These results demonstrate that MCA occlusion induces a long lasting increase in neuronal histamine release in the rat striatum. Key Words: Histamine-Microdialysis-Rat Striatum-Middle cerebral artery occlusion.
1982; Gross et a!., 1982) . Brain edema induced by systemic injection of kainic acid is attenuated by pretreatment with HA H 2 -receptor antagonists (Sztriha et a!. , 1987) . The opioid-induced increase in BBB permeability to sodium fluorescein is inhib ited by an intracerebroventricular injection of H 2 -antagonists or a-fluoromethylhistidine (a-FMH) (Oishi et a!. , 1989a) , a specific inhibitor of histidine decarboxylase (Kollonitsch et a!., 1978) . Therefore, it is possible that brain HA is responsible for some of the pathological changes induced by brain isch emia. We have already demonstrated that middle cerebral artery (MeA) occlusion induces gradual in creases in the levels of HA and tele-methyl histamine, a predominant metabolite of brain HA, in the rat striatum and cerebral cortex (Adachi et a!. , 1991) .
Intracerebral microdialysis has been developed to measure extracellular concentrations of neuro transmitters in restricted brain regions of living an imals (Ungerstedt et a!. , 1982; Westerink et a!., 1987) . One of the advantages of this technique is the lack of serious tissue damage. This is because per fusion fluid does not come in direct contact with brain tissue. Histaminergic neuronal activity has been reported to be severely depressed by some anesthetic agents (Pollard et ai., 1973; Baba et ai., 1987) . Thus, anesthesia may well change the dy namic states of extracellular HA as measured by in vivo microdialysis. In the present experiment, therefore, we characterized the release of HA from the striatum of conscious freely moving rats using intracerebral microdialysis, and studied the change in the extracellular HA concentration in the stria tum after MeA occlusion.
MATERIALS AND METHODS

Animals
Male Wi star rats weighing 250-300 g (Japan SLC Inc., Shizuoka, Japan) were housed in groups in a room con trolled at 22 ± 2°C and maintained in an alternating 12 h light/dark cycle (lights automatically on at 0600 h). Food and water were given ad libitum. All experiments were performed between 0900 and 1800 h to avoid the influence of circadian variation of HA metabolism (Oishi et aI., 1987) .
Microdialysis probe
The dialysis probe was obtained from Eicom (BDP-UI-8-03, Kyoto, Japan). The probe was U shaped and con sisted of a loop of cellulose membrane tubing (6 mm long, 0.22 mm outside diameter, molecular weight cutoff at 50,000) protruding by 3 mm from the end of a 22-gauge stainless steel tube.
Probe implantation
Rats were anesthetized with intraperitoneal injection of pentobarbital sodium (50 mg/kg) and placed in a stereo taxic apparatus (Narishige Scientific Instrument, Tokyo, Japan). The skull was then exposed and a burr hole was drilled to insert a dialysis probe into the right striatum. The coordinates were 0.5 mm anterior and 3.5 mm lateral to the bregma and 6.8 mm below the skull surface. The probe was fixed to the skull with an anchor screw and dental cement. At the end of the experiment, rats were decapitated and the location of the dialysis probe was verified.
Perfusion
Ringer's solution (NaCl, 147 mM; KCl, 4 mM; CaCI2, 2.3 mM) was prepared from sterile distilled water imme diately before use, since bacterial contamination may cause erroneous increases in the amount of HA in the dialysates. When perfused with a high-K + medium, the KCI concentration increased to 100 mM and the NaCI concentration was reduced to maintain isomolarity. On the day after implantation, Teflon tubing (0.12 mm out side diameter) was connected to each end of the stainless steel tube of the implanted probe and perfusion fluid was supplied from one side at a rate of 1 J.LlImin. Brain perfu sates were collected every 30 min into microtubes con taining 30 J.LI of 0.2 M perchloric acid. An in vitro recov ery test was performed by immersing the dialysis probe J Cereb Blood Flow Me/ab, Vol. 12, No. 3, 1992 into 37°C Ringer's solution containing 10 nM of HA. The recovery of HA into the perfusate was 37.7 ± 2.8% (mean ± SD, n = 4), when the probe was perfused for 30 min at 1 J.LI/min.
Systemic drug administration
Polyethylene tubing (0.2 mm inside diameter) was im planted in the peritoneum on the day before brain mi crodialysis. When evaluating the effects of a-FMH and (R)-a-methylhistamine [(R)-a-MH], the drugs were in jected via this tubing without handling the animals.
Cerebral ischemia
On the day after probe implantation, the right carotid artery was exposed under ether anesthesia and the root of the MCA was occluded by inserting a silicone-coated ny lon thread, according to the method of Koizumi et al. (1986) . This method has been shown to produce ischemic infarcts in the ipsilateral caudoputamen and the surround ing cortex (Koizumi et aI., 1986) . All MCA-occluded rats showed marked paralysis of the contralateral limbs. Im mediately after surgery, brain perfusion with Ringer's so lution was started. The effect of MCA occlusion on the HA output was statistically evaluated by comparing val ues in MCA-occluded rats with those in sham-operated rats.
Determination of HA
To determine the HA concentration in brain microdi alysates, we used ion-pair reversed-phase HPLC coupled with postcolumn o-phthalaldehyde derivatization fluo rometry (Itoh et aI., in press ). We used this method be cause it enabled us to measure HA in microdialysates containing (R)-a-MH, which had the same retention time as that of HA and interfered with the HA assay in cation exchange HPLC with postcolumn derivatization. The HPLC system consisted of a pump (LC 6A, Shimadzu, Kyoto, Japan) serving to deliver mobile phase, three pumps (SP-T2501 U, Nihon Seimitsu Kagaku, Tokyo, Ja pan) serving to deliver reagents independently, a sample injector with a 100-J.LI sampling loop (Model 7125, Rheo dyne, Cotati, CA, U.S.A.) a guard column (J.LBondapack Cl8 Guard Pak, Waters, Milford, MA, U.S.A.), a re versed-phase separation column (150 x 4.0 mm inside diameter) packed with Chemcosorb 5 ODS-H (Chemco, Osaka, Japan), a thermostatic reactor (RE 8010, Tosoh, Tokyo, Japan), and a fluorescence spectromonitor (RF-535, Shimadzu). Mobile phase was 0.16 M KH2P04 con taining 0.1 mM sodium octane sulfonate (pH 4.5) and the flow rate was 0.6 mllmin. Fifty microliter aliquots of the mixture of brain microdialysates and perchloric acid were directly injected into the HPLC system. The eluate from the separation column was allowed to react with a mix ture of 2.5 M NaOH (0.12 mllmin) and 0.1 % o-phthalal dehyde solution (0.12 mllmin) in a coil of Teflon tubing (5 m x 0.25 mm inside diameter) at 50°C to form fluorescent derivatives, and then 4 M H3P04 (0.14 mllmin) was added to the mixture from another Teflon tube (2 m x 0.25 mm inside diameter) to stop the reaction. The fluorescence intensity (peak height) was measured at an excitation wavelength of 355 nm and an emission wavelength of 450 nm.
In this HPLC assay, the amount of HA injected was linearly related to the fluorescence intensity from 0.5 to 1,000 pg, and the detection limit was 0.5 pg of HA when the signal to noise ratio was 2.
Statistical analysis
The data were evaluated by one-way analysis of vari ance (in testing the effects of drugs or a high concentra tion of K + ) or two-way analysis of variance (in testing the effect of MCA occlusion). The effects of drugs or a high concentration of K + on each fractional 0.5 h HA output were evaluated by Dunnett's test by comparing each frac tional posttreatment value with the basal value immedi ately before treatment (the zero-time value). The effect of MCA occlusion on the HA output was evaluated by Dun nett's test by comparing each fractional value in the MCA-occluded group with each corresponding fractional value in the sham-operated group.
Chemicals and drugs
HA dihydrochloride and o-phthalaldehyde were pur chased from Nakalai Tesque (Kyoto, Japan). Pentobar bital sodium was obtained from Abbott Laboratories 
RESULTS
Chromatograms of brain microdialysates
Chromatograms of the standard containing 10 pg of HA and 30-min fractions of microdialysates from the rat striatum are shown in Fig. I . The retention times of HA was 8. 4 min (Fig. IA) . The chromato gram of a basal 30-min fraction had a peak at the same retention time as that of HA, and its height approximately equaled the peak height of 8 pg of HA (Fig. lB) . Figure IC shows the increased HA output from the striatum 4 h after MCA occlusion.
Basal HA output
The basal HA output of intact animals was fairly constant from I to 7 h after the start of perfusion and there were no significant variations in the 0. 5 h fractional values. The fractional outputs during this 6-h period ranged from 5. 9 ± 1.6 to 8. 4 ± 1.6 pg/30 min (mean ± SD of five animals). Based on the in vitro recovery of HA through the dialysis mem brane (37.7%), the extracellular HA concentration in the striatum was calculated to be 4.7-6.7 nM.
Influences of pharmacological manipulations on HA output
When at least three consecutive 0. 5 h outputs were stable, the effect of drugs on the HA output was tested by adding them to the perfusion medium or injecting them intraperitoneally. Perfusion with a high-K + (100 mM)-containing medium for 30 min produced a significant (140%) increase in the frac tional HA output ( Fig. 2A) . The HA output re turned to the basal level when the medium was re placed by normal Ringer's solution. On the other hand, perfusion with a tetrodotoxin (1 f..L M) containing medium markedly decreased the 0. 5 h HA outputs to 32-35% of the mean basal value for the first 2-h period after the beginning of perfusion (Fig. 2B) . Intraperitoneal injection of a-FMH (100 mg/kg) produced a marked and long-lasting reduc- tion in the HA output (Fig. 3A) . The HA in the perfusate decreased immediately after a-FMH in jection and had almost completely disappeared 4 h after the treatment. The HA output also decreased immediately after intraperitoneal injection of 5 mg/ kg (R)-a-MH (Fig. 3B) . The 0. 5 h HA outputs from 1 to 2.5 h after (R)-a-MH injection were only about 12% of the mean basal output. Thereafter, the HA output gradually recovered but the fractional values were still significantly lower than the basal values 5. 5 h after injection.
Effects of MeA occlusion on HA output Figure 4 shows the changes in HA output from the striatum after MeA occlusion. In the sham operated group, the HA output was 5. 8-8.3 pg/30 min from 1 to 8 h after the operation, and there was no significant variation. These fractional HA output values obtained in the sham-operated group were in almost the same range as that of values (5.9-8.4 pg/30 min) obtained in intact animals. On the other hand, in the MeA-occluded group, the 0. 5 h frac tional HA outputs were significantly higher than the control values starting 2 h after occlusion and gradually increased to 409% of the control value after 8 h. Figure 5 shows the effect of MeA occlusion on the HA output in rats injected intraperitoneally with metoprine (10 mg/kg), a potent inhibitor of HA N-methyltransferase (Duch et aI. , 1978) , 10 min be fore occlusion. In the sham-operated group, the fractional HA outputs were markedly high (20--30 pg/30 min) owing to inhibition of HA metabolism, but there was no significant variation over 8 h. In the MeA-occluded group, the fractional outputs were slightly but not significantly higher than the values in the sham-operated group during the first 3. 5 h after occlusion. The HA output gradually in creased thereafter and reached a value of about 100 pg/30 min 8 h after occlusion. Intraperitoneal administration of a-FMH (100 mg/kg) 10 min before MeA occlusion produced a prolonged decrease in the HA output in both groups. The fractional HA outputs from 2 to 3. 5 h after the sham operation were 1. 3 ± 0.7, 1. 5 ± 1. 3, and 0.7 ± 0. 2 pg (mean ± SD, n = 5). The 0. 5 h HA outputs were 3.4 ± 1. 6, 1. 9 ± 1. 8, and 1. 5 ± 1. 3 pg (mean ± SD, n occlusion.
5) from 2 to 3.5 h after MCA
DISCUSSION
There are multicompartmental HA pools, such as neuronal and mast cell pools, in the rat brain (Mar tres et aI., 1975; Garbarg et aI., 1976) . A marked difference between neuronal and mast cell HA pools is that neuronal HA turns over rapidly, with a half-life of less than 1 h, while mast cell HA turns over very slowly, with a half-life of several days (Martres et aI., 1975; Garbarg et aI., 1976) . There fore, the HA depleted within the first few hours after treatment with a-FMH, a specific and irre versible histidine decarboxylase inhibitor, can be regarded as neuronal in origin (Garbarg et aI., 1980; Maeyama et aI., 1982; Oishi et aI., 1984) . In the present experiment, the HA output was reduced by a-FMH below the detection limit, suggesting that the extracellular HA in the striatum of conscious freely moving rats is neuronal in origin. This view is also supported by the following: First, the extracel lular HA concentration was greatly reduced by per fusion with a medium containing tetrodotoxin, which blocks sodium channels and inhibits neuronal electrical activity (Narahashi, 1974) (Fig. 2B) . Sec ond, an Hrreceptor agonist, (R)-a-MH, markedly decreased the HA concentration immediately after injection (Fig. 3B) . H3-receptors are located on his taminergic nerve terminals, where HA inhibits its own release and synthesis via stimulation of these receptors (Arrang et aI., 1983 (Arrang et aI., , 1985 . (R)-a-MH and thioperamide are the most potent and specific cur rently available agonist and antagonist, respec tively, at Hrreceptors (Arrang et aI., 1987) . Both in vivo and in vitro experiments have demonstrated that these drugs strongly inhibit and facilitate, re spectively, the release of HA in the rodent brain (Arrang et aI., 1987; Garbarg et aI., 1989; Oishi et aI., 1989b) . In addition, in our previous experiment (Itoh et aI., 1991) , the HA concentration in microdi alysate of the rat hypothalamus was elevated by systemic administration of thioperamide.
In contrast to the present results, Russell et ai. (1990) reported that the extracellular HA in the stri atum of chloral hydrate-anesthetized rats showed little response to perfusion with a high-K + medium. However, in their experiments, microdialysis was started 1 h after insertion of the dialysis probe. The lack of effect of the depolarizing stimulus on striatal HA might be due to tissue damage. Indeed, Wes terink and De Vries (1988) have shown in the rat striatum that the extracellular dopamine does not respond to either tetrodotoxin perfusion or Ca 2 + removal from the perfusion medium when the mi crodialysis is started within 3 h but not 24 h after insertion of a U-shaJed dialysis probe.
Recently, Cumming et ai. (1991) reported, using microdialysis, an extremely high concentration of extracellular HA in the striatum of conscious freely moving rat (50 nM) than the levels observed in the present experiments (4.7-6.7 nM). This may be due to contamination by histamine synthesized by bac teria grown in the dialysis system including perfu sion medium or derived from other sources such as mast cells and inflammatory cells. The extremely high HA concentration may explain the failure of tetrodotoxin to decrease the HA output as reported in their experiments. Thus, much caution should be used in performing a microdialysis study on HA as we described.
The results of the present study on cerebral isch emia show that MCA occlusion induces an increase in the HA output from the rat striatum. There is no high-affinity uptake of HA in the brain, and the HA released from nerve terminals is predominantly methylated by HA N-methyltransferase to tele methylhistamine (Schwartz et aI., 1971; Schayer and Reilly, 1973) . Therefore, the increased HA out put in MCA-occluded rats may be due to facilitation of HA release and/or inhibition of HA N-methyl transferase. This inhibition of enzyme activity may be due to a decreased supply of S-adenosylmethio nine. In the present experiment, in rats treated with metoprine, MCA occlusion produced no significant changes in the HA output for the first 3. 5 h but it generally increased the output thereafter. These re sults suggest that the initial increase in the HA out put after MCA occlusion is mainly due to an inhi bition of HA metabolism while the more marked HA output observed later is due to enhancement of HA release combined with inhibition of HA metab olism. In the present study, the fractional HA out put increased to about three times the control value 1 h after treatment with metoprine. However, no significant changes were observed thereafter, prob ably due to activation of presynaptic Hrreceptors that regulate HA release (Arrang et aI., 1983) . Therefore, it is also likely that MCA occlusion im pairs the regulatory function of Hrreceptors.
In the present study, systemic administration of a-FMH completely inhibited the MCA occlusion induced increase in HA output, which suggests that the increased HA in the perfusate was neuronal in origin. It is unlikely that mast cells or other inflam matory cells containing HA infiltrate the ischemic tissue and lead to increased HA levels. The delay of the a-FMH-induced decrease in HA output in MCA-occluded rats may also be due to inhibition of HA N-methyltransferase.
In conclusion, the present study demonstrates for the first time that most of the HA collected by in tracerebral microdialysis of the striatum is neuronal in origin and that MCA occlusion induces a marked and continuous increase in the extracellular HA concentration in the striatum of conscious freely moving rats. To elucidate the functional signifi cance of the elevated HA concentration in the ex tracellular space after ischemia, experiments are underway on the histopathological changes in the ischemic brains of rats after modification of hista minergic neuronal activity.
